Senator Chuck Grassley, chairman of the Senate Judiciary Committee, opened an executive business meeting on March 26 to discuss the Combating Illicit Xylazine Act, additional legislation, and nominations for federal marshal positions.
The work of the Senate Judiciary Committee is significant because it affects constitutional protections and public safety nationwide through its legislative and oversight duties, according to the official website. The committee also aims to uphold the Constitution by reviewing legislation, overseeing federal law enforcement, and evaluating judicial nominations.
In his opening statement, Grassley addressed recent developments related to an Arctic Frost hearing. He said that "this committee won’t give in to the Democrats’ ill-advised strategy to bring Jack Smith in before the record is ready." Grassley also commented on criticism regarding fired Department of Justice and FBI personnel: "Let me remind my colleagues that many of the fired personnel retaliated against my whistleblowers during the Biden administration. I didn’t hear a peep from my Democratic colleagues then about their lives being upended and destroyed." He added that investigating government weaponization continues because his Democratic colleagues "didn’t lift a finger during the Biden administration."
The agenda included votes on two nominations—Brian Gootkin as Marshal in Montana and James Stuart as Marshal in Minnesota—as well as three bills: S. 545 (Combating Illicit Xylazine Act), H.R. 2159 (Count the Crimes to Cut Act), and S. 2934 (Protecting Americans from Russian Litigation Act of 2025). Grassley highlighted bipartisan support for S. 545: "Our bill will classify this highly toxic drug as Schedule III under the Controlled Substances Act, while protecting its legitimate use by veterinarians, farmers and ranchers." He noted it is cosponsored by both Democrats and Republicans.
Grassley described efforts made over several days with senators from both parties to clarify language within S. 545: "This new language is explicit about what documents we expect to be produced by both HHS [Health and Human Services] and DEA [Drug Enforcement Administration]." The manager’s amendment requires combined scientific evaluations from HHS alongside regulatory assessments from DEA for public release: "They will submit this along with DEA’s law enforcement, regulatory and abuse evaluation in a combined, public and prompt report to Congress...the information available to the public will closely mimic data published if xylazine was administratively scheduled," he said.
The Senate Judiciary Committee serves as a standing committee of the U.S. Senate with authority over judicial matters across Washington D.C., led by a chair who oversees meetings attended by senators from both major political parties according to its official website.
Looking ahead at broader implications, Grassley stated that exposing political corruption remains ongoing work for his committee: "This committee’s work exposing that political corruption will continue."
